Brief: Solara Active Pharma Says U.S FDA Compeletes Inspection At Solara Research Centre, Chennai
14/12/2018 11:21
Dec 14 (Reuters) - Solara Active Pharma Sciences Ltd
SOLA.NS :
* SAYS COMPLETION OF US FDA INSPECTION AT SOLARA RESEARCH
CENTRE,
CHENNAI WITH ZERO 483S INSPECTIONAL OBSERVATIONS
Source: https://reut.rs/2SP8lXe
Further company coverage: SOLA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees